双重负调节性 T 细胞和抗原呈递细胞相互作用对免疫反应抑制的后果。

Consequences of double negative regulatory T cell and antigen presenting cell interaction on immune response suppression.

机构信息

Transplantation Institute and Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.

出版信息

Int Immunopharmacol. 2011 May;11(5):597-603. doi: 10.1016/j.intimp.2010.11.015. Epub 2010 Nov 23.

Abstract

Recent studies have indicated that regulatory T cell (Treg)-mediated suppression may depend on interactions with antigen presenting cells (APCs). TCRαβ(+)CD3(+)CD4(-)CD8(-)NK1.1(-) double-negative (DN) Tregs have been shown to be able to suppress effector T cells in vitro in mice and humans, and control various diseases in an antigen (Ag)-specific manner in murine models. Studies on DN Tregs have been focused on their suppressive effect on T cells. However, the nature of APCs that can effectively activate DN Tregs as well as the effect of DN Tregs on APCs, have not previously been studied. In this report, we investigated the interactions of DN Tregs with APCs. We found that although stimulation with naïve allogeneic APCs could activate DN Tregs, it failed to induce proliferation of DN Tregs. Interestingly, stimulation with LPS-activated allogeneic APCs significantly augmented the proliferation of DN Tregs compared to naïve allogeneic APCs. Importantly, the expanded DN Tregs can maintain their suppressive function. Further, DN Tregs proliferated in the presence of LPS-activated B cells in an Ag-specific fashion. Although DN Tregs were not able to down regulate the expression of CD80 or CD86 on LPS-activated B cells, they could kill activated allogeneic as well as syngeneic B cells via a perforin-dependent pathway, indicating that eliminating activated B cells may contribute to DN Treg-mediated suppression. These data provide important insights into the interactions of DN Tregs with APCs and may facilitate production of functional Ag-specific DN Tregs in a clinical setting.

摘要

最近的研究表明,调节性 T 细胞 (Treg) 介导的抑制作用可能依赖于与抗原呈递细胞 (APC) 的相互作用。TCRαβ(+)CD3(+)CD4(-)CD8(-)NK1.1(-)双阴性 (DN) Treg 已被证明能够在体外抑制小鼠和人类的效应 T 细胞,并以抗原 (Ag)-特异性方式在小鼠模型中控制各种疾病。对 DN Treg 的研究一直集中在其对 T 细胞的抑制作用上。然而,能够有效激活 DN Treg 的 APC 的性质以及 DN Treg 对 APC 的影响,以前尚未研究过。在本报告中,我们研究了 DN Treg 与 APC 的相互作用。我们发现,尽管刺激幼稚同种异体 APC 可以激活 DN Treg,但不能诱导 DN Treg 增殖。有趣的是,与幼稚同种异体 APC 相比,用 LPS 激活的同种异体 APC 刺激显著增强了 DN Treg 的增殖。重要的是,扩增的 DN Treg 可以保持其抑制功能。此外,DN Treg 在 LPS 激活的 B 细胞存在下以 Ag 特异性方式增殖。尽管 DN Treg 不能下调 LPS 激活的 B 细胞上 CD80 或 CD86 的表达,但它们可以通过穿孔素依赖性途径杀死激活的同种异体和同基因 B 细胞,表明消除激活的 B 细胞可能有助于 DN Treg 介导的抑制。这些数据提供了关于 DN Treg 与 APC 相互作用的重要见解,并可能有助于在临床环境中产生功能性 Ag 特异性 DN Treg。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索